Naproxen Sodium PM
- Product NDC
- 55910-854
- 11-digit product format
- 559100854
- Labeler code
- 55910
- Product ID
- 55910-854_a662cc95-9cef-4ee0-a4bd-c75b20392d78
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
- Application
- ANDA209726
- Marketing category
- ANDA
- Marketing start
- 2018-12-31
- Marketing end
- 2025-09-30
- Substance
- DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55910-854 | NAPROXEN SODIUM PM (NAPROXEN SODIUM) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)] | 3 | Legacy NDC | 20221203_a16d1925-c01e-4a00-ba01-e9d699b65e7d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55910-854-20 | 55910085420 | 1 BOTTLE, PLASTIC in 1 BOX (55910-854-20) > 20 TABLET in 1 BOTTLE, PLASTIC | 2018-12-31 | 0000-00-00 | No | No | Current |
| 55910-854-40 | 55910085440 | 1 BOTTLE, PLASTIC in 1 BOX (55910-854-40) > 40 TABLET in 1 BOTTLE, PLASTIC | 2018-12-31 | 0000-00-00 | No | No | Current |